Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage III Malignant Melanoma of Skin AJCC V6”

321 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 321 results

Early research (Phase 1)Study completedNCT00005633
What this trial is testing

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT07565285
What this trial is testing

The Efficacy and Safety of PRTX007-003 Combined With Pembrolizumab in Resectable Stage III Melanoma

Who this might be right for
Melanoma Stage III
Primmune Therapeutics, Inc. 48
Testing effectiveness (Phase 2)WithdrawnNCT04495010
What this trial is testing

Neoadjuvant Nivolumab+Ipilimumab Followed by Adjuvant Nivolumab or Neoadjuvant Nivolumab+Ipilimumab Followed by Adjuvant Observation Compared With Adjuvant Nivolumab in Treatment-Naive High-risk Melanoma Participants

Who this might be right for
Melanoma
Bristol-Myers Squibb
Testing effectiveness (Phase 2)Looking for participantsNCT05970497
What this trial is testing

A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors

Who this might be right for
CancerMelanoma Stage IIIMelanoma Stage IV+1 more
Krystal Biotech, Inc. 240
Large-scale testing (Phase 3)UnknownNCT00002455
What this trial is testing

Immunotherapy After Surgery in Treating Patients With Breast Cancer, Colon Cancer, or Melanoma

Who this might be right for
Breast CancerColorectal CancerMelanoma (Skin)
Centro Oncologico de Excelencia
Large-scale testing (Phase 3)Study completedNCT00003789
What this trial is testing

Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Locally Advanced Melanoma of the Arm or Leg

Who this might be right for
Recurrent MelanomaStage III Melanoma
National Cancer Institute (NCI) 216
Testing effectiveness (Phase 2)UnknownNCT00004025
What this trial is testing

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Genzyme, a Sanofi Company 36
Early research (Phase 1)Study completedNCT00004016
What this trial is testing

Interferon Gamma in Treating Patients With Recurrent or Metastatic Melanoma or Other Solid Tumors

Who this might be right for
Melanoma (Skin)Unspecified Adult Solid Tumor, Protocol Specific
University of Rochester
Not applicableAvailableNCT04853602
What this trial is testing

IFx-Hu2.0 Expanded Access Program

Who this might be right for
Cutaneous Melanoma, Stage IIICutaneous Melanoma, Stage IVMerkel Cell Carcinoma+1 more
TuHURA Biosciences, Inc.
Early research (Phase 1)Ended earlyNCT02097225
What this trial is testing

Onalespib, Dabrafenib, and Trametinib in Treating Patients With BRAF-Mutant Melanoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Who this might be right for
BRAF V600E Mutation PresentBRAF V600K Mutation PresentMetastatic Malignant Solid Neoplasm+7 more
National Cancer Institute (NCI) 22
Testing effectiveness (Phase 2)UnknownNCT05827770
What this trial is testing

The Efficacy and Safety of Neoadjuvant Toripalimab Combined With Temozolomide in Resectable Stage III Melanoma

Who this might be right for
Melanoma Stage III
Yong Chen 20
Testing effectiveness (Phase 2)Ended earlyNCT01605162
What this trial is testing

Phase 2 Study of the Poly(ADP-Ribose) Polymerase Inhibitor E7016 in Combination With Temozolomide in Subjects With Wild Type BRAF Stage IV or Unresectable Stage III Melanoma

Who this might be right for
Wild Type BRAF Stage IV MelanomaUnresectable Stage III Melanoma
Eisai Inc. 8
Testing effectiveness (Phase 2)Ended earlyNCT00104884
What this trial is testing

FR901228 in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma

Who this might be right for
Malignant MelanomaMelanoma
ECOG-ACRIN Cancer Research Group 4
Testing effectiveness (Phase 2)Temporarily pausedNCT03384836
What this trial is testing

Propranolol Hydrochloride and Pembrolizumab in Treating Patients With Stage IIIC-IV Melanoma That Cannot Be Removed by Surgery

Who this might be right for
Stage IIIC Cutaneous Melanoma AJCC v7Stage IV Cutaneous Melanoma AJCC v6 and v7
Roswell Park Cancer Institute 47
Testing effectiveness (Phase 2)Study completedNCT02259231
What this trial is testing

RTA 408 Capsules in Patients With Melanoma - REVEAL

Who this might be right for
MelanomaUnresectable (Stage III) MelanomaMetastatic (Stage IV) Melanoma
Biogen 41
Early research (Phase 1)Study completedNCT00004065
What this trial is testing

Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+9 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00003222
What this trial is testing

Vaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
University of Virginia 40
Not applicableEnded earlyNCT04577729
What this trial is testing

The IRMI-FMT Trial

Who this might be right for
Fecal Microbiota TransplantationMalignant Melanoma Stage IIIMalignant Melanoma Stage IV
Medical University of Graz 5
Early research (Phase 1)Looking for participantsNCT03819296
What this trial is testing

Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer

Who this might be right for
Clinical Stage 0 Cutaneous Melanoma AJCC v8Clinical Stage I Cutaneous Melanoma AJCC v8Clinical Stage IA Cutaneous Melanoma AJCC v8+41 more
M.D. Anderson Cancer Center 800
Testing effectiveness (Phase 2)Study completedNCT00019890
What this trial is testing

Vaccine Therapy in Treating Patients With High-Risk Stage III or Completely Resected Metastatic Melanoma

Who this might be right for
Stage IV MelanomaStage III MelanomaRecurrent Melanoma
National Cancer Institute (NCI)
Next Page